Title Statements
- Full title :Advances in psoriasis : a multisystemic guide / Jeffrey M. Weinberg, Mark Lebwohl, editors.
Summary
This extensively revised second edition provides an up-to-date and highly informative textbook on psoriasis. The understanding of the mechanisms behind the disease and the available treatment options have continued to develop rapidly in recent times, with this vital resource covering the latest in these management options, including targeted T-cell therapy, the use of immunomodulators, systemic therapies, and ultraviolet and laser therapy. In addition, it provides a detailed overview of the pathophysiology, comorbidities, epidemiology and triggers of the disease. Advances in Psoriasis: A Multisystemic Guide extensively details the scientific basis and practice management of psoriasis. It is therefore a vital resource for practicing and trainee dermatologists looking to develop their clinical knowledge of how to manage and treat these patients.
Read More ↓Edition Statements
- Publication Date:2021
- Edition:Second edition
Publication Statements
- Publisher(s):Springer
- Place of Publication:Cham, Switzerland
- Language:eng
- Publication Date:2021
Notes
Previous edition: 2014.
Includes index.
The Physical Object
- Description:1 online resource (415 pages) : : illustrations (some color)
Edition Identifiers
- ISBN:9783030548599, 3030548597
- DOI:10.1007/978-3-030-54859-9
- oclc:on1232278283
- LC Classification:RL321
- Dewey Decimal:616.5/26
Table of Contents
Introduction to and History of Psoriasis and Psoriasis Therapy -- Pathophysiology of Psoriasis/Novel Pathways -- Psoriasis: Clinical Review and Update -- Psoriasis: Epidemiology, Potential Triggers, Disease Course -- Topical Therapy I: Corticosteroids and Vitamin D Analogues -- Topical Therapy II: Retinoids, Immunomodulators, and Others -- Topical Therapy II: Retinoids, Immunomuodulators, and Others/ Ultraviolet Therapy for Psoriasis -- Laser Therapy for Psoriasis -- Traditional Systemic Therapy I: Methotrexate and Cyclosporine -- Traditional Systemic Therapy II: Retinoids and Others -- Apremilast -- Etanercept -- Adalimumab -- Infliximab, Golimumab, and Certolizumab Pegol -- Ustekinumab -- Guselkumab -- Tidrakizumab -- Risankizumab -- Secukinumab -- Ixekizumab -- Brodalumab -- Biosimilars for Psoriasis -- Research Pipeline I: Oral Therapeutics for Psoriasis -- Research Pipeline II: Upcoming Biologic Therapies -- Pediatric Psoriasis -- Challenges in Psoriasis Treatment: Nail, Scalp, and Palmoplantar Involvement -- Psoriasis and Comorbidities -- Summary of Published Treatment Guidelines -- Index.
Read More ↓Subjects
Writers
No reviews yet. Be the first to rate this work.
Rate & Review